Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 DeFi Kingdoms DeFi Kingdoms +1,091.75%
#4 Black Phoenix Black Phoenix +334.12%
#5 aPriori aPriori +117.60%
#6 Bedrock Bedrock +71.13%
#7 Cysic Cysic +42.73%
#8 Prom Prom +38.17%
#9 COTI COTI +34.60%
#10 Playnance Playnance +34.46%
Coin of the day
Wrapped One Wrapped One
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Shanrong Biotechnology Corp. Shanrong Biotechnology Corp.

Shanrong Biotechnology Corp.

SRBT
Rang in Aktien #42715
Shanrong Biotechnology Corp. primarily functions as a provider of executive... Shanrong Biotechnology Corp. primarily functions as a provider of executive consulting and project management services. The company specializes in the modernization of armored vehicles, integrating advanced digital communications into their systems. Furthermore, it furnishes critical spare parts and specialized equipment to both military and law enforcement organizations. Beyond hardware provision, its service portfolio also encompasses on-site maintenance, along with comprehensive training programs for maintenance personnel, operators, and tactical operations. Shanrong's expertise additionally extends to program oversight, business expansion initiatives, and strategic analysis within the defense, homeland security, information technology, and telecommunications industries. The entity, formerly known as Defense Solutions Holding, Inc., officially adopted its current name, Shanrong Biotechnology Corp., in September 2017. It is headquartered in Beverly Hills, California.
Aktienkurs
$0.0001
Zuletzt synchronisiert: 2026-08-10
Marktkapitalisierung
$298.00
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-99.92%
Land
US
Handel Shanrong Biotechnology Corp. (SRBT)

Kategorie

Financial Services
P/B-Verhältnis für Shanrong Biotechnology Corp. (SRBT)
P/B-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Shanrong Biotechnology Corp. beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/B-Verhältnis bei 0.
P/B-Verlauf für Shanrong Biotechnology Corp. von 2026 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/B-Verhältnis P/B-Verhältnis-Differenz Land
Clone Algo Technologies Inc. Clone Algo Technologies Inc.
Clone Algo Technologies Inc.
CATI.US
 - -
US
Worldwide Webb Acquisition Corp. Worldwide Webb Acquisition Corp.
Worldwide Webb Acquisition Corp.
WWAC.US
 - -
US
Gushen, Inc. Gushen, Inc.
Gushen, Inc.
GSHN.US
 - -
CN
Apollo Strategic Growth Capital Apollo Strategic Growth Capital
Apollo Strategic Growth Capital
APSG.US
 - -
US
Digital World Acquisition Corp. Digital World Acquisition Corp.
Digital World Acquisition Corp.
DWAC.US
 - -
US